Our development services (CDO) include upstream and downstream process development, and formulation development. We have extensive experience improving target protein/plasmid yield and isolating it from complex matrices by developing, and optimizing fermentation and purification processes. We have been involved in the research, development and manufacturing of various large molecules, including recombinant subunit vaccines, virus-like particles (VLPs), Nano-antibodies/ heavy-chain variable (VHH)/ single domain antibody (sdAb), antibody fragments (Fab, scFv), peptides/hormones (insulin, GLP-1, growth hormone), cytokines (Interleukin-2/IL-2, IL-15, IL-21), growth factors (EGF, FGF, NGF, KGF, KDGF), enzymes, plasmid DNA, collagens, etc.